Article
Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia – An <b><i>in vivo</i></b> study
3 Feb 2006
Abstract excerpt
Intrinsic or acquired resistance to vincristine (VCR), an antimicrotubule agent used in the treatment of childhood acute lymphoblastic leukemia (ALL), is a major clinical problem. Using a clinically relevant NOD/SCID mouse xenograft model of ALL, we established that alterations in the actin and tubulin cytoskeleton are involved in in vivo VCR resistance. Altered protein expression between VCR-sensitive ALL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
